Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Identification of MHC class II-restricted T-cell epitopes in prostate-specific membrane antigen.

Clinical cancer research : an official journal of the American Association for Cancer Research - 15 Aug 2003

Schroers Roland, Shen Lei, Rollins Lisa, Xiao Zhen, Sonderstrup Grete, Slawin Kevin, Huang Xue F, Chen Si-Yi

Abstract excerpt

An effective tumor vaccine may be required to induce both CTLs and T-helper (Th) responses against tumor-associated antigens. CD4+ Th cells that recognize MHC class II-restricted epitopes play a central role in the initiation and maintenance of antitumor immune responses. Prostate-specific membrane antigen (PSMA) is highly expressed in prostate cancer and thus is a potential target for prostate cancer...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antigens, Surface
Share to CD4 Antigens

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cell Separation

Share to Epitopes, T-Lymphocyte

Share to Histocompatibility Antigens Class II

Share to Immunotherapy

Share to Peptide Biosynthesis

Share to Transgenes

Source

Identifiers

PMID: 12960111

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Identification of MHC class II-restricted T-cell epitopes in prostate-specific membrane antigen.PMID 12960111Read ↗

Prostate-related antigen-derived new peptides having the capacity of inducing prostate cancer-reactive CTLs in HLA-A2+ prostate cancer patients.Semantic proximity Read ↗

Identification of peptide vaccine candidates for prostate cancer patients with HLA-A3 supertype alleles.Semantic proximity Read ↗

An HLA-A3-binding prostate acid phosphatase-derived peptide can induce CTLs restricted to HLA-A2 and -A24 alleles.Semantic proximity Read ↗

DNA vaccines for the treatment of prostate cancerSemantic proximity Read ↗

Cancer Peptide Vaccine Therapy Developed from Oncoantigens Identified through Genome-wide Expression Profile Analysis for Bladder CancerSemantic proximity Read ↗

Binding of prostate-specific membrane antigen to dendritic cells: a critical step in vaccine preparation.Semantic proximity Read ↗

Induction of human cytotoxic T lymphocytes specific for prostate-specific antigenSemantic proximity Read ↗

A library of cancer testis specific T cell receptors for T cell receptor gene therapySemantic proximity Read ↗

Evaluation of Phage Display Discovered Peptides as Ligands for Prostate-Specific Membrane Antigen (PSMA)Semantic proximity Read ↗

Identification of HLA-DRB1*1501-restricted T-cell epitopes from human prostatic acid phosphatase.Semantic proximity Read ↗

Isolation of human prostate cancer cell reactive antibodies using phage display technologySemantic proximity Read ↗

Recognition of a Ubiquitous Self Antigen by Prostate Cancer-Infiltrating CD8 <sup>+</sup> T LymphocytesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.